Filter
402
Text search:
drug
import
Featured
25
114
Language
Document type
196
82
71
26
15
4
4
2
2
Countries
24
15
12
12
12
11
11
11
10
9
9
9
8
7
7
7
7
6
6
5
4
4
4
4
4
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
200
25
20
15
8
5
Toolboxes
55
30
26
21
17
13
13
10
7
7
6
6
5
3
3
3
2
2
2
2
1
1
1
Towards a Healthier Botswana
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
Statutory Instrument 150 of 1991 | S.I. 150 of 1991 | Amended by S.I.’ s 298/93, 61/94, 319/94, 199/98, 256/98, 36/99, 24/2001 and 257/2002, 105 and 222 /2004
Tackling Tuberculosis in Under-Served Populations: A Resource for TB Control Boards and their partners
Harm Reduction Journal (2016) 13:28
DOI 10.1186/s12954-016-0118-x
Interferon-γ Assays - Description and Assessment of a New Tool in the Diagnosis of Tuberculosis.
Haür B et al. Interferon-γ-Tests in der ...Pneumologie 2006; 60: 29-44
The third edition, released in 2018, has grown to include a total of 18 chapters, contributed by 20 experts and authors from many countries. The goal remains the same: to educate primary care providers on the best practices in TB diagnosis, treatment and follow-up. All articles are richly illustrate
...
SITUATION ANALYSIS AND RECOMMENDATIONS
